Metabolism Flashcards
Primary lactose intolerance
Age-dependent decline after childhood (absence of lactase-persistent allele)
Common in people of Asian, African or NA descent
Intestinal biopsy reveals normal mucosa in pts with hereditary lactose intolerance
Secondary lactose intolerance
Loss of brush boarder enzyme due to gastroenteritis (e.g. Rotavirus), autoimmune disease, etc.
Congenital lactose intolerance
Rare, but due to a defective gene
Urea Cycle
Amino acid catabolism results in the formation of common metabolite (e.g. Pyre ate, actual-CoA) which serve as metabolic fuels
Excess nitrogen (NH3) generate by this process is converted to urea and excreted by kidneys
Ordinarily (Ornithine), Careless (Carbomoyl Phosphate) Crappers (Citruline) Are (Aspartate) Also (Arginosuccinate) Frivolous (Fumarate) About (Arginine) Urination (Urea)
Hyperammonemia
Can be acquired (e.g. Liver disease) or hereditary (urea cycle enzyme deficiencies)
Results in excess NH3 which depletes alpha-KG, leading to inhibition of the TCA cycle
Clinical findings: tremor (asterixis), slurring of speech, somnolence, vomiting, cerebral edema, blurring of vision
Treatment of Hyperammonemia
Treatment to decrease ammonia levels:
lactose to acidity the GI tract and trap NH4+ for excretion
Rifaximin to decrease colonic ammoniagenic bacteria
Benzoate, phenyl acetate or phenyl iterate to bind NH4+ and lead to excretion
Glycogen: Skeletal muscle
Glycogen undergoes glyconeolysis to glucose 1-phosphate to glucose 6 phosphate, which is rapidly metabolized during exercise
Glycogen
Storage form of glucose
Branches have alpha (1-6) bonds
Linkages have alpha (1-4) bonds
Glycogen: hepatocytes
Stored and undergoes glyconeolysis to maintain blood sugar at appropriate levels
Glycogen phosphorylase liberates glucose 1-phosphate residues off branched glycogen until four glucose units remain on a branch
Then 4-alpha-glucanotransferase moves three molecules of glucose 1-phosphate from branch to the linkage
Then alpha-1,6-glycosidase cleaves off the last residue, liberating glucose
Fatty Acid Metabolism
Fatty acid synthesis requires transport of citrate from mitochondria to cytoskeleton
Predominantly occurs in liver, lactating mammary glands and adipose tissue
Long chain FA degradation requires carnitine-dependent transport into the mitochondrial matrix
Ketone bodies
Ketones: acetone, acetoacetate, beta-hydroxybutyrate
In the liver FAs and AAs are metabolized to acetoacetate and beta-HB to be used by muscle and brain
In prolonged starvation and DKA, oxaloacetate is depleted for glyconeogeneis
In alcoholism, excess NADH shuts oxaloacetate to maleate
Both processes cause a build up of acetyl-CoA, which shunts glucose and FFA toward the production of ketone bodies
Fed State
Glycolysis and aerobic respiration
Insulin stimulates storage of lipids, proteins and glycogen
Fasting
Hepatic glycogenolysis (major); hepatic glyconeogeneis, adipose release of FFA (minor) Glucagon and Epi stimulate use of fuel reserves
Starvation days 1-3
Blood glucose levels maintained by:
Hepatic glycogenolysis
Adipose release of FFA
Muscle & liver which shift fuel use from glucose to FFA
Hepatic glyconeogenesis from peripheral tissue lactate and alanine and from adipose tissue glycerol and propionyl-CoA
Glycogen reserves depleted after day 1
RBCs lack mitochondria and therefore cannot use ketones
Starvation after day 3
Adipose stores (ketone bodies become main source of energy for the brain).
After these are depleted, vital protein degradation accelerates, leading to organ failure and death
Amount of excess stores determines survival time
Apolipoprotein E
Mediates remnant uptake
Present in chylomicron, chylomicron remnant, VLDL, IDL and HDL
Apolipoprotein A-I
Activates LCAT
Present in: chylomicron and HDL
Apolipoprotein C-II
Lipoprotein lipase co-factor
Present in Chylomicron, HDL and VLDL
Apolipoprotein B-48
Mediates chylomicron secretion
Present in chylomicron so, chylomicron remnant
Apolipoprotein B-100
Binds LDL receptor
Present in VLDL, IDL and LDL
Lipoprotein functions
Lipoproteins are composed of varying proportions of cholesterol, TGs, and phospholipids
LDL and HDL carry the most cholesterol
LDL
transports cholesterol from liver to tissues
LDL is Lousy
Formed by hepatic lipase modification of IDL in the liver and peripheral tissue
Taken up by target cells via receptor mediated endocytic is
HDL
Transports cholesterol from the periphery to liver
HDL is Healthy
Mediates reverse cholesterol transport. Acts as repository for apolipoproteins C & E (which are needed for chylomicron and VLDL metabolism)
Secreted from both liver and intestine
alcohol increases synthesis
Chylomicron
Delivers dietary TGs to peripheral tissue
Delivers cholesterol to liver in the form of chylomicron remnants, which are mostly depleted of their TGs
Secreted by intestinal epithelial cells
VLDL
Delivers hepatic TGs to peripheral tissue
Secreted by liver
IDL
Formed in the degradation of VLDL
Delivers TG and cholesterol to the liver
Lactase decificiency
Insufficient lactase enzyme leading to dietary lactose intolerance
Lactase functions on the brush border to digest lactose into glucose and galactose
Stool demonstrates a decreased pH and breath shows increased H content with lactose hydrogen breath test
Findings: Bloating, cramps, flatulence, osmotic diarrhea
Treatment: avoid dairy products or add lactase pills to diet
Ethanol metabolism
Ethanol – alcohol dehydrogenase –acetaldehyde
Acetaldehyde – acetaldehyde dehydrogenase – acetate
Both steps require NAD+ to NADH (NAD+ is the limiting reagent)
Alcohol dehydrogenase
Zero order kinetics
Fomepizole
Inhibits alcohol dehydrogenase and is an antidote for methanol or ethylene glycol poisoning
Disulfiram
Inhibits acetaldehyde dehydrogenase
Acetaldehyde accumulates contributing to hangover symptoms
Ethanol metabolism Increase NADH/NAD+ ratio
Causes:
Pyruvate to lactate conversion (lactic acidosis)
Oxaloacetate to malate (prevents gluconeogenesis- fasting hypoglycemia)
Dihydroxyacetone phosphate to glycerol-3-phosphate (combines with FAs to make TGs - hepatosteatosis)
Disfavors TCA production of NADH - increased utilization of acetyl-CoA for ketogenesis (ketoacidosis) and lips genesis (hepatosteatosis)
Metabolism: Mitochondria
FA oxidation (beta-oxidation), acetyl-CoA production, TCA cycle, oxidative phosphorylation, ketogenesis
Metabolism: Cytoplasm
Glycolysis, HMP shunt, and synthesis of steroids (SER), proteins (ribosomes, RER), FAs, cholesterol and nucleotides
Metabolism: Both mitochondria and cytoplasm
Heme synthesis, urea cycle, gluconeogenesis
HUGs take two (i.e. Both)
Kinase
Catalyzes transfer of a phosphate group from a high energy molecule (usually ATP) to a substrate (eg phosphofructokinase)
Phosphorylase
Adds inorganic phosphate onto a substrate without using ATP (eg glycogen phosphorylase)
Phosphatase
Removes phosphate onto substrate (eg fructose 1,6 bisphosphatase)
Dehydrogenase
Catalyzes oxidation-reduction reactions (eg pyruvate dehydrogenase)
Hydroxylase
Adds hydroxyl group (OH) onto substrate (e.g. Tyrosine hydroxylase)
Carboxylase
Transfers CO2 groups with help of biotin (pyruvate carboxylase)
Mutase
Relocates a functional group within a molecule (eg vitamin B12 dependent methylmalonyl-CoA)
Rate Determining enzyme: glycolysis
Enzyme: phosphofructokinase-1 (PFK-1)
Regulators: AMP (+), fructose-2,6-bisphosphate (+), ATP (-), citrate (-)
Rate Determining enzyme: Gluconeogenesis
Enzyme: Fructose 1,6, bisphosphate
Regulators: AMP (-), fructose 2,6-bisphosphate (-)
Rate Determining enzyme: TCA cycle
Enzyme: Isocitrate dehydrogenase
Regulators: ADP (+), ATP (-), NADH (-)
Rate Determining enzyme: Glycogenesis
Enzyme: glycogen synthase
Regulators: glucose-6-phosphate (+), insulin (+), cortisol (+), Epi (-), glucagon (-)
Rate Determining enzyme: Glycogenolysis
Enzyme: glycogen phosphorylase
Regulators: Epi (+), glucagon (+), AMP (+), glucose-6-phosphate (-), insulin (-), ATP (-)
Rate Determining enzyme: HMP shunt
Enzyme: glucose-6-phosphate dehydrogenase
Regulators: NADP+ (+), NADPH (-)
Rate Determining enzyme: De novo pyrimidine synthesis
Enzyme: carbamoyl phosphate synthetase II
Regulators: ATP (+), PRPP (+), UTP (-)
Rate Determining enzyme: De novo purine synthesis
Enzyme: glutamine phosphoribosylpyrophosphate (PRPP) amindotransferase
Regulators: AMP (-), inosine monophosphate (IMP) (-), GMP (-)
Rate Determining enzyme: Urea cycle
Enzyme: carbamoyl phosphate synthetase I
Regulators: N-acetylglutamate (+)
Rate Determining enzyme: FA synthesis
Enzyme: acetyl-CoA carboxylase (ACG)
Regulators: insulin (+), citrate (+), glucagon (-), palmitoyl-CoA (-)
Rate Determining enzyme: FA oxidation
Enzyme: carnitine acyltransferase I
Regulators: Malonyl-CoA (-)
Rate Determining enzyme: Ketogenesis
Enzyme: HMG-CoA synthase
Rate Determining enzyme: Cholesterol synthesis
Enzyme: HMG-CoA reductase
Regulators: insulin (+), thyroxin (+), glucagon (-), cholesterol (-)
ATP production
Aerobic metabolism of glucose produces 32 net ATP via malate-aspartate shuttle (heart and liver)
30 net ATP via glycerol-3-phosphate shuttle (muscle)
Anaerobic glycolysis produces only 2 net ATP per glucose molecule
ATP hydrolysis can be coupled to energetically unfavorable reactions
Arsenic causes glycolysis to produce 0 ATP
Activated carriers
ATP: phosphoryl groups NADH, NADPH, FADH2: electrons CoA, lipoamide: Acyl groups Biotin: CO2 Tetrahydrofolates: 1-carbon units S-adenosylmethionine (SAM): CH3 groups TTP: aldehydes
Universal electron acceptors
Nicotinamides (NAD+ from VitB3, NADP+)
NAD+ is generally used in catabolic processes to carry reducing equivalents away as NADH
NADPH (product of HMP shunt) is used in anabolic processes (steroid and FA synthesis) as a supply of reducing equivalents
Uses of NADPH
Anabolic processes
Respiratory burst
Cytochrome P-450 system
Glutathione reductase
First committed step of glycolysis
Phosphorylation of glucose to yield glucose-6-phosphate
Reaction is either catalyzes by hexokinase or glucokinase, depending on the tissue
At low glucose concentrations hexokinase sequesters glucose in the tissue. At high glucose concentrations excess glucose is stored in the liver
Hexokinase
Location: most tissues, except liver and pancreatic beta cells Km: lower (increased affinity) Vmax: lower (decreased capacity) Induced by insulin: No Feedback inhibited by G6P: Yes Gene mutation associate with MODY: No
Glucokinase
Location: liver, beta cells of pancreas Km: higher (decreased affinity) Vmax: higher (increased capacity) Induced by insulin: yes Feedback inhibited by G6P: No Gene mutation associated with MODY: yes
Glycolysis regulation
Net glycolysis (cytoplasm) Glucose + 2Pi + 2ADP + 2NAD+ -- 2 pyruvate + 2ATP + 2NADH + 2H+ + 2H2O